Cynosure Inc.
Chelmsford, MA 01824
Share:
Laser Workstation treats difficult vascular lesions.
CynergyÃ-® Workstation with MultiPlex(TM) technology enables rapid sequential emission of pulse-dye and Nd:YAG wavelengths from same optical fiber, with short time delay between 2 pulses. When combined, 2 wavelengths are effective for treating many vascular lesions such as portwine stains and difficult facial telangiectasia.
Read More »Laser Workstation suits aesthetic and medical practices.
Cynergy III Aesthetic Workstation includes 2 lasers plus breakaway pulsed light system that can be used in workstation or can be unplugged for use at other locations. Baby-safe pulse dye laser technology is suited for treating vascular lesions and fine telangiectasias, while skin-safe Nd:YAG laser removes hair and treats larger veins on face and legs. Wavelengths from 500-950 nm treat red and...
Read More »Cynosure to Present at 10th Annual Needham Healthcare Conference
Presentation to be Webcast Live at 2:00 p.m. ET Tuesday, April 5 WESTFORD, Mass., March 28, 2011 - Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the 10th Annual Needham Healthcare Conference in New York City. The presentation by President and Chief Executive Officer Michael...
Read More »Cynosure to Present at 4th Annual Maxim Group Growth Conference
Presentation to be Webcast Live at 1:30 p.m. ET Thursday, November 18 WESTFORD, Mass., Nov. 10, 2010 -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the Maxim Group Growth Conference in New York on Thursday, November 18. The presentation by Executive Vice President,...
Read More »Cynosure to Present at UBS Global Life Sciences Conference
Presentation to be Webcast Live at 3:00 p.m. ET Tuesday, September 21 WESTFORD, Mass., Sept. 16 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it will present at the UBS Global Life Sciences Conference in New York on Tuesday, September 21. The presentation by President and Chief Executive...
Read More »Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
WESTFORD, Mass., March 11 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Chief Financial Officer Tim Baker will present at the following institutional investor conferences in March: o On Monday, March 17, the Company will present at the...
Read More »Cynosure to Webcast Presentation from 10th Annual Needham & Company Growth Conference
WESTFORD, Mass., Jan. 2 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that its senior management will be presenting at the 10th Annual Needham & Company Growth Conference. The conference is being held January 8 - 11 at The New York Palace Hotel. Cynosure's presentation will be webcast live over...
Read More »Cynosure to Present at the RBC Capital Markets Healthcare Conference
WESTFORD, Mass., Dec. 5 -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the RBC Capital Markets Healthcare Conference on Wednesday, December 12, 2007 at 10:00 a.m. ET from The Westin New York at Times Square, New York. President and Chief Executive Officer Michael...
Read More »Cynosure to Present at the Citigroup 2007 Healthcare Conference
WESTFORD, Mass., May 15: Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the upcoming Citigroup Healthcare Conference on Tuesday, May 22, 2007 at 1:20 p.m. ET from the New York Hilton. President and Chief Executive Officer Michael Davin and Chief Financial Officer...
Read More »Cynosure Selected as Exclusive Technology Provider for U.K.-Based Skin Laser Clinics
WESTFORD, Mass., Sept. 21 /PRNewswire-FirstCall/ -- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that it has entered into an agreement to become the exclusive technology provider for new skin treatment clinics being opened by sk:n Ltd. in the United Kingdom. Under the agreement, Cynosure will supply...
Read More »Cynosure Expands International Distribution Capabilities with Opening of Second Office in Japan
WESTFORD, Mass., Aug. 23-- Cynosure, Inc. (NASDAQ:CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced the opening of its second sales and service office in Japan. The Company's newest office is in Osaka, Japan's second largest city, which has a population exceeding 10 million. The Osaka location complements Cynosure's existing...
Read More »Laser Workstation treats difficult vascular lesions.
CynergyÃ-® Workstation with MultiPlex(TM) technology enables rapid sequential emission of pulse-dye and Nd:YAG wavelengths from same optical fiber, with short time delay between 2 pulses. When combined, 2 wavelengths are effective for treating many vascular lesions such as portwine stains and difficult facial telangiectasia.
Read More »